Product Information
FELBAMATE 400 MG TABLET is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.7265 per EA under NDC 53746073490. Its NADAC has been published 198 times since Nov 9, 2022.
FDA first approved this application on Sep 13, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
53746073490
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FELBAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA201680FDA Approved
9/13/2011
TE Code
AB
On Market Since
8/10/2022
Pharmacological Classes
Price Statistics
The NADAC for FELBAMATE 400 MG TABLET has been published 198 times since Nov 9, 2022, and over the history we have for it it has declined 60.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7265 per EA |
|---|---|
| All-time high | $1.8248 (Dec 14, 2022) |
| All-time low | $0.6785 (Jul 22, 2026) |
| 52-week high | $1.0316 |
| 52-week low | $0.6785 |
| Median price | $0.9901 |
| Average price | $0.9939 |
| Largest weekly change | -42.2% (Dec 21, 2022) |
| Weeks tracked | 198 |
| Tracking since | Nov 9, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FELBAMATE 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FELBAMATE 400 MG TABLET, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.7265 per EA (NDC 53746073490), effective Aug 19, 2026.
How has the price of FELBAMATE 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for FELBAMATE 400 MG TABLET has declined 60.2%. It has been tracked across 198 weekly CMS publications since Nov 9, 2022.
What are the highest and lowest recorded NADAC prices for FELBAMATE 400 MG TABLET?
Since Nov 9, 2022, the NADAC for FELBAMATE 400 MG TABLET has ranged from a low of $0.6785 (Jul 22, 2026) to a high of $1.8248 (Dec 14, 2022), with a median of $0.9901 per EA.
Are there cheaper alternatives to FELBAMATE 400 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FELBAMATE 400 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FELBAMATE 400 MG TABLET?
FELBAMATE 400 MG TABLET (NDC 53746073490) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.